To assist investigators in complying with the NIH data safety monitoring policy, please visit guidance and sample DSMP templates on the NIH website.
See also:
- NINDS Glossary of Clinical Research Terms
- NIH Policy for Data and Safety Monitoring
- Further Guidance on a Data and Safety Monitoring for Phase I and Phase II Trials
- FDA Guidance for Clinical Trial Sponsors
- FDA: Oversight of Clinical Investigations
National Institute of Diabetes and Digestive and Kidney Diseases (NDDK):
DSMP Guidelines from various NIH Institutes:
- National Cancer Institute (NCI)
- National Eye Institute (NEI)
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Child Health & Human Development (NICHD)
- National Heart, Lung and Blood Institute (NHLBI)
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Institute of Mental Health (NIMH)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- National Institute of Neurological Disorders and Stroke (NINDS)